Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 427

Oxygen deprivation drives dysfunctional neutrophil immunity

Low oxygen levels in the blood can alter the genetic makeup of key immune cells, weakening the body’s ability to fight infection, new research shows.

Scientists found that oxygen deprivation – known as hypoxia – changes the genetic material of immune cells called neutrophils, reducing their capacity to destroy harmful microbes.

The team discovered that low oxygen appears to leave a lasting mark on the bone marrow cells that produce neutrophils, meaning the impact can persist after oxygen levels return to normal.

Screening of Single-Domain Antibodies to Adeno-Associated Viruses with Cross-Serotype Specificity and a Wide pH Tolerance

Adeno-associated virus (AAV) vectors are the preferred gene delivery tool in gene therapy owing to their safety, long-term gene expression, broad tissue tropism, and low immunogenicity. Affinity ligands that can bind multiple AAV serotypes endure harsh clean-in-place (CIP) conditions and are critical for industrial-scale purification. However, current ligands lack broad serotype recognition and adequate alkaline stability, which limits their reusability in large-scale manufacturing. In this study, we employed a competitive biopanning strategy to isolate a single-domain antibody (VHH) that simultaneously binds AAV2, AAV8, and AAV9. The VHH retained structural integrity and binding activity after exposure to 0.1 M NaOH, demonstrating robust alkaline stability.

Adipokines as Clinically Relevant Therapeutic Targets in Obesity

Adipokines provide an outstanding role in the comprehensive etiology of obesity and may link adipose tissue dysfunction to further metabolic and cardiovascular complications. Although several adipokines have been identified in terms of their physiological roles, many regulatory circuits remain unclear and translation from experimental studies to clinical applications has yet to occur. Nevertheless, due to their complex metabolic properties, adipokines offer immense potential for their use both as obesity-associated biomarkers and as relevant treatment strategies for overweight, obesity and metabolic comorbidities. To provide an overview of the current clinical use of adipokines, this review summarizes clinical studies investigating the potential of various adipokines with respect to diagnostic and therapeutic treatment strategies for obesity and linked metabolic disorders.

Imaging of Skull Base Tumors

The skull base provides a platform for supporting the brain while serving as a conduit for major neurovascular structures. In addition to malignant lesions originating in the skull base, there are many benign entities and developmental variants that may simulate disease. Therefore, a basic understanding of the relevant embryology is essential. Lesions centered in the skull base can extend to the adjacent intracranial and extracranial compartments; conversely, the skull base can be secondarily involved by primary extracranial and intracranial disease. CT and MRI are the mainstay imaging methods and are complementary in the evaluation of skull base lesions. Advances in cross-sectional imaging have been crucial in the management of patients with skull base pathology, as this represents a complex anatomical area that is hidden from direct clinical exam.

How Taiwan’s Giant Genomics Project Is Rewriting the Future of Disease Prediction

A sweeping genomic effort in Taiwan has revealed something that global precision medicine has long overlooked, that the best way to predict disease is to study the people who will be living with its consequences. Researchers at Academia Sinica have now shown that building genetic risk tools tailored to Han Chinese populations can transform how common illnesses are forecast and understood.

In work published in Nature on October 15, 2025, scientists analyzed genomic and clinical data from more than half a million participants in the Taiwan Precision Medicine Initiative. By conducting the largest genome wide association analysis of Han Chinese individuals to date, they developed the first population specific polygenic risk score models for diseases ranging from type 2 diabetes to autoimmune disorders to heart disease, achieving markedly stronger accuracy than tools based on European data. “This project marks a milestone for precision medicine in East Asia,” said Dr. Cathy S. J. Fann, senior corresponding author at Academia Sinica. “By integrating large scale genomic and clinical data, we are building predictive models that truly reflect the real genetic architecture of our population.”

Simple molecule shows remarkable Alzheimer’s reversal in rats

Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The treatment restored memory and reduced inflammation in rats, while also proving non-toxic and able to cross the blood–brain barrier. Because it’s far simpler and potentially cheaper than existing drugs, researchers are now pursuing partnerships to begin human trials.

A new space radiation shield: Flexible boron nitride nanotube film shows promise

High-energy cosmic radiation damages cells and DNA, causing cancer, and secondary neutrons—generated especially from the planetary surfaces—can be up to 20 times more harmful than other radiations. Aluminum, the most widely used shielding material, has the drawback of generating additional secondary neutrons when below a certain thickness.

Consequently, (BNNTs), which are lightweight, strong, and possess excellent neutron shielding capabilities, are emerging as a promising alternative.

BNNTs are ultrafine tubular only about 5 nanometers in diameter—roughly 1/20,000 the thickness of a human hair—making them extremely light and strong, with excellent thermal neutron absorption capability. However, due to limitations in fabrication technology, they have so far only been produced into thin and brittle sheet, restricting their practical applications.

MIT Invents Injectable Brain Chips

Not exactly a brain chip per se by a bit of nanotech.

While companies like Elon Musk’s Neuralink are hard at work on brain-computer interfaces that require surgery to cut open the skull and insert a complex array of wires into a person’s head, a team of researchers at MIT have been researching a wireless electronic brain implant that they say could provide a non-invasive alternative that makes the technology far easier to access.

They describe the system, called Circulatronics, as more of a treatment platform than a one-off brain chip. Working with researchers from Wellesley College and Harvard University, the MIT team recently released a paper on the new technology, which they describe as an autonomous bioelectronic implant.

As New Atlas points out, the Circulatronics platform starts with an injectable swarm of sub-cellular sized wireless electronic devices, or “SWEDs,” which can travel into inflamed regions of the patient’s brain after being injected into the bloodstream. They do so by fusing with living immune cells, called monocytes, forming a sort of cellular cyborg.

/* */